Skip to main content
Clinical Trials/NCT05560698
NCT05560698
Completed
N/A

A Motivation-enhancing Intervention to Retain Participants in a Trial After Treatment With Allergen Immunotherapy

University of Aarhus1 site in 1 country224 target enrollmentSeptember 26, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Grass Pollen Allergy
Sponsor
University of Aarhus
Enrollment
224
Locations
1
Primary Endpoint
Rate of reporting daily cSMS data
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

The motivation-enhancing intervention is designed for participants in the ILIT.NU trial. The participants are patients with hay fever who are treated with a vaccination in an inguinal lymph node. The motivation-enhancing intervention is a web-based app developed in collaboration with patient partners and is intended to increase retention and reporting in the ILIT.NU trial.

Detailed Description

The ILIT.NU trial (EudraCT 2020-001060-28) investigates whether patient reported outcome measures compound symptom-medication score (cSMS) are relieved by intralymphatic immunotherapy (ILIT). The participants are asked for a three-year period to attend annual consultations and to daily fill in an online questionnaire about their allergy symptoms and medication use during the grass pollen season (100 days). High attrition rates have been a problem in previous ILIT trials. High attrition affects generalizability, validity and reliability of a trial. To increase retention and reporting in the ILIT.NU trial, a motivation-enhancing web-based app has been developed. The web app is based on the Self-Determination Theory and is developed in collaboration with patient partners and clinicians. Participants are randomized across treatment group to either the motivation-enhancing web app or the standard reporting method. The project is conducted as a Study Within a Trial (SWAT).

Registry
clinicaltrials.gov
Start Date
September 26, 2022
End Date
June 30, 2024
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants enrolled in the ILIT.NU trial

Exclusion Criteria

  • Participants not enrolled in the ILIT.NU trial, Denmark

Outcomes

Primary Outcomes

Rate of reporting daily cSMS data

Time Frame: 16 weeks

Increased reporting will be compared within and between the intervention group and the control group, to evaluate the effectiveness of the motivation-enhancing intervention

Secondary Outcomes

  • Motivation(14 days)
  • Participant experience with the web-based app(12 weeks)
  • Retention(16 weeks)

Study Sites (1)

Loading locations...

Similar Trials